PATENT REGISTER | |||||||||||||||||||
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2015/040 2016/042 | |||||||||||||||||||
Status | Revoked by EPO | Patent No. | 1641822 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Application No. | 04754234.5 | Date of Filing | 02/06/2004 | ||||||||||||||||
Date Grant Published | 15/05/2013 | Application Published | 10/01/2005 | ||||||||||||||||
Title of Invention | IL-17 A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF | ||||||||||||||||||
Priority |
|
||||||||||||||||||
Inventors |
ARNOTT, David GURNEY, Austin HASS, Philip LEE, James WU, Yan |
||||||||||||||||||
Current Proprietor |
Genentech, Inc. 1 DNA Way South San Francisco CA 94080-4990 UNITED STATES OF AMERICA |
||||||||||||||||||
Address for service |
F.F. GORMAN & CO. 15 Clanwilliam Square Dublin 2 IRELAND |
||||||||||||||||||
Renewal Fees |
|
||||||||||||||||||
Publication Language | English | ||||||||||||||||||
Translation Received Date | |||||||||||||||||||
23/05/2013 | Divisional Application number: 10010285.4 Publication number: 2277908 Date of receipt: 23/09/2010 | ||||||||||||||||||
21/06/2013 | Address for Service recorded as F.F. GORMAN & CO., 15 Clanwilliam Square, Dublin 2, Ireland received on 20/06/2013. | ||||||||||||||||||
21/07/2015 | Request for grant a Supplementary Protection Certificate, citing Patent number 1641822 as the relevant basic patent, in respect of the product Secukinumab filed on 13/07/2015. Reference number of request is 2015/040. | ||||||||||||||||||
26/10/2016 | Request for grant a Supplementary Protection Certificate, citing Patent number 1641822 as the relevant basic patent, in respect of the product Ixekizumab filed on 24/10/2016. Reference number of request is 2016/042. | ||||||||||||||||||
17/04/2020 | Request for grant of Supplementary Protection Certificate No. 2015/040 withdrawn on 17/04/2020. | ||||||||||||||||||
17/04/2020 | Request for grant of Supplementary Protection Certificate No. 2016/042 withdrawn on 17/04/2020. | ||||||||||||||||||
30/07/2020 | Status on register changed from Granted to Revoked by EPO with legal effect from 10/1/2020. | ||||||||||||||||||
29/09/2020 | Year 17 renewal fee has been refunded and removed as the patent was revoked by the EPO with effect from 10/01/2020.Overpayment recovered from EPO with Qtr 3 2020 renewals payment. |